Scientific Terms
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development
Pfizer intends to use Guardant's blood-based tests in global clinical trials, with specific plans to evaluate the clinical utility of its Reveal assay as clinical trial surrogate endpoint.
Akoya, Singapore Consortium Collaborate to ID Markers of Response to Checkpoint Inhibitor Therapy
The project will use Akoya's PhenoCode Discovery IO60 Panel to look at matched pairs of immuno-oncology exceptional responders and hyper-progressors.
The company's data is still preliminary, but it believes its approach could help reduce unnecessary prostate biopsies and aid in cancer monitoring and screening.
Invivoscribe's LabPMM Nabs NY State Approval for MRD Assay
The company can now offer the FLT3 ITD MRD Assay in New York state to assess measurable residual disease to guide treatment for acute myeloid leukemia patients.
The Sunshine Genetics Act would establish a consortium that plans to sequence 10,000 newborns for up to 600 rare conditions.